Manik Hospital And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
as on 28-12-2024
- Paid Up Capital ₹ 5.50 M
as on 28-12-2024
- Company Age 20 Year, 9 Days
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 97.00 Cr
as on 28-12-2024
- Satisfied Charges ₹ 13.82 Cr
as on 28-12-2024
- Revenue 25.09%
(FY 2021)
- Profit 155.98%
(FY 2021)
- Ebitda -8.39%
(FY 2021)
- Net Worth 7.28%
(FY 2021)
- Total Assets 1.68%
(FY 2021)
About Manik Hospital And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 5.50 M.
The company currently has active open charges totaling ₹97.00 Cr. The company has closed loans amounting to ₹13.82 Cr, as per Ministry of Corporate Affairs (MCA) records.
Makarand Kanjalkar, Sandhya Kondpalle, and Ulhas Kondpalle serve as directors at the Company.
- CIN/LLPIN
U85110MH2004PTC150303
- Company No.
150303
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2004
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
- Apps
Who are the key members and board of directors at Manik Hospital And Research Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Makarand Kanjalkar  | Director | 30-Dec-2004 | Current |
| Sandhya Kondpalle | Director | 30-Dec-2004 | Current |
| Ulhas Kondpalle | Director | 30-Dec-2004 | Current |
Financial Performance of Manik Hospital And Research Centre.
Manik Hospital And Research Centre Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 25.09% increase. The company also saw a substantial improvement in profitability, with a 155.98% increase in profit. The company's net worth moved up by a moderate rise of 7.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manik Hospital And Research Centre?
In 2021, Manik Hospital And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Jan 2024 | ₹42.50 Cr | Open |
The Pandharpur Urban Co-Op. Bank Ltd. Creation Date: 05 May 2022 | ₹1.00 Cr | Open |
Others Creation Date: 31 Mar 2022 | ₹2.00 Cr | Open |
How Many Employees Work at Manik Hospital And Research Centre?
Unlock and access historical data on people associated with Manik Hospital And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manik Hospital And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manik Hospital And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
